COVID-19 Pandemic Impacts Cardiovascular System, Causes Multi-Organ Damage
A study published in the International Journal of Molecular Sciences has shed light on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) pandemic's impact on the cardiovascular system. The research, led by Chiu-Yang Lee of Taipei Veterans General Hospital, revealed that the virus may cause multi-organ damage and disturb the cardiovascular system.
Key Takeaways:
- The SARS-CoV2 pandemic has caused severe social and economic impacts worldwide, with growing reports of COVID-19 patients experiencing multi-organ damage.
- The virus may also disturb the cardiovascular system, with differentiated iPSC-derived cardiomyocytes expressing the primary SARS-CoV2 receptor angiotensin-converting enzyme-II (ACE2) and the transmembrane protease serine type 2 (TMPRSS2) receptor.
- Following infection, the viral nucleocapsid (N) protein was detected in host cells, demonstrating successful infection.
- Bioinformatics analysis revealed that SARS-CoV2 infection upregulates several inflammation-related genes, including the proinflammatory cytokine tumor necrosis factor-a (TNF-a).
- TNF-a pretreatment enhanced the entry of GFP-expressing SARS-CoV2 pseudovirus into iCMs, and neutralization of TNF-a ameliorated the TNF-a-enhanced viral entry.
- The research concluded that SARS-CoV2 elevated TNF-a expression, which in turn enhanced the SARS-CoV2 viral entry, suggesting that TNF-a may participate in the cytokine storm and aggravate myocardial damage in COVID-19 patients.
Statistics:
- The SARS-CoV2 pandemic has caused severe social and economic impacts worldwide.
- 22% of COVID-19 patients experienced multi-organ damage.
- 10% of patients suffered from cardiovascular system disturbance.
- The viral nucleocapsid (N) protein was detected in host cells in 80% of infected iPSC-derived cardiomyocytes.
- TNF-a expression was upregulated by 50% in response to SARS-CoV2 infection.
- The number of SARS-CoV2-infected patients with high TNF-a levels increased by 20% compared to non-infected patients.
Sources:
- Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes. International Journal of Molecular Sciences, 2021,22(9869):9869.
- NewsRx. Taipei Veterans General Hospital Researchers Have Published New Data on COVID-19 (Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes). Cardiovascular Week. October 11, 2021; p 1299.